1. Volume 377, Issue 9777, Pages 1580-1587 (May 2011)
Risk of triple-class virological failure in children with HIV: a retrospective cohort study 
The Lancet 
Volume 377, Issue 9777, Pages (May 2011)
DOI: /S (11)
Copyright © 2011 Elsevier Ltd Terms and Conditions

2. Figure 1
Inclusion criteria for initial regimens and definition of triple-class virological failure in the main analysis and the comparison of children with adults
TCVF=triple-class virological failure. NRTI=nucleoside or nucleotide reverse transcriptase inhibitors. NNRTI=non-NRTI. PI/r=ritonavir-boosted protease inhibitor. PI=protease inhibitor. uPI=unboosted protease inhibitor.
The Lancet  , DOI: ( /S (11) )
Copyright © 2011 Elsevier Ltd Terms and Conditions

3. Figure 2
Incidence per 100 person-years (95% CI) of triple-class virological failure in children with HIV by duration of antiretroviral therapy
*At end of year 9.
The Lancet  , DOI: ( /S (11) )
Copyright © 2011 Elsevier Ltd Terms and Conditions